17 web-programmer-developer-"https:" "https:" "https:" "https:" "https:" "Medical Research Council" Fellowship positions at University of London
Sort by
Refine Your Search
-
potential candidates who meet the essential criteria. The post is full-time 35 hours per week, 1.0 FTE and fixed-term until 30 July 2027. The post is funded by the UK Medical Research Council and is available
-
in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice. The Medical Research Council Unit The Gambia is among
-
& International Health is seeking to appoint a Research Fellow in Health Data Science (with a focus on machine learning) to NeoShield , a multi-country implementation research programme focused on neonatal sepsis
-
at the intersection of inflammation biology, therapeutic development, and precision medicine, contributing to projects aimed at elucidating pathogenic mechanisms and identifying druggable targets. The programme
-
. Supported by a BHF Programme Award, this role offers an excellent opportunity for a motivated clinician to pursue academic cardiology in a leading research environment. The Fellow will contribute
-
post or completed CCT and looking for the opportunity to undertake an out of program research project to result in the award of a PhD. You will have obtained MRCP or equivalent and be working towards
-
. The goals are to develop a greater understanding of basic mechanisms of immunological protection versus pathology, and to apply this knowledge to the development of interventions and the identification
-
with experience in metagenomics and diagnostics research. The postholder will be clinically qualified and will contribute to studies focused on developing and conducting studies focused on developing
-
endemic countries. We are seeking to appoint a Research Fellow to join a research programme that applies advanced bioinformatic, statistical, and population genomic approaches to large-scale sequencing data
-
and to integrate these lines into the drug-development pipeline to aid the discovery of novel therapeutics that eliminate “persister” parasites. This will involve undertaking research on Trypanosoma